MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Fitbit’s Role in the Fight to Understand COVID-19

Fitbit is leading the charge in the effort to gain a better understanding of COVID-19. On this episode of Let’s Talk Medtech we spoke with Dr. Conor Heneghan Lead Research Scientist at Fitbit about a recent study the company conducted regarding the virus.

Late last year, Nature Partner Journal, npj Digital Medicine published findings from Fitbit’s COVID-19 study, which aims to determine whether the wearable can help build an algorithm to detect COVID-19 before symptoms start.

The published results show that breathing rate, resting heart rate and heart rate variability (HRV) are all useful metrics for indicating the onset of illness, making wearables a key tool in the fight against COVID-19, as it’s clear that patients' bodies may signal impact from the disease before more noticeable symptoms appear. 

 On this episode of Let’s Talk Medtech, MD+DI’s managing editor Omar Ford spoke with Dr. Conor Heneghan Lead Research Scientist at Fitbit about the study. Click here for the episode. 





Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.